drug

Ketamine 0.58

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Eastern Finland
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Touchscreen-based Cognitive Tests in Healthy Volunteers
NCT03469089Phase 1Unknown

KOLs & investigators

1
Markus M Forsberg, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Eastern Finland
company
trial
Touchscreen-based Cognitive Tests in Healthy Volunteers
PHASE1
trial
indication
Neurobehavioral Manifestations
indication
Schizophrenia
indication
Schizophrenia
indication
Cognitive Symptom
indication
KOL
Markus M Forsberg, PhD
KOL score —
person